FACULTY
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Tamara R. Fountain, MD
Professor and Section Chair Emeritus
Oculofacial Plastic Surgery
Department of Ophthalmology
RUSH University Medical Center
Chicago, IL
PROGRAM OVERVIEW
This podcast series aims to increase the target clinicians’ awareness of factors that contribute to health disparities in patients with ocular disorders and potential barriers to care. Learn about leadership style and why increasing diversity within the eye care workforce is essential to patient care along with strategies for increasing representation. Enhance appreciation of the need for diverse representation in research in clinical trials, as this can lead to better access, and acquire tactics to increase underrepresented minority enrollment in clinical trials.
TARGET AUDIENCE
This activity is designed to meet the educational needs of clinicians in ophthalmology, retina specialties and optometry.
LEARNING OBJECTIVES
- Define factors that contribute to health disparities in patients with ocular diseases
- Formulate strategies to increase the participation of underrepresented groups in the eye care workforce
- Devise tactics to encourage increased diverse representation in research and clinical trials
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Judy E. Kim, MD has participated on the advisory boards for Allergan, Astellas, Clearside Biomedical, DORC, Genentech, Notal Vision, Novartis, Outlook Therapeutics and Regeneron. Dr. Kim has conducted research for Optos.
Tamara R. Fountain, MD has participated as an Independent Board Director for RxSight and Sight Science.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chimene Richa, MD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this activity. To receive CME/CNE credit participants must:
- Read the CME information and faculty disclosures.
- Complete the pre-test before listening.
- Participate in the activity by listening to the podcast.
- Complete online post-test and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: April 21, 2023
EXPIRATION DATE: April 21, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Adrienne W. Scott, MD
Chief, Wilmer Eye Institute – Bel Air
Associate Professor
Department of Ophthalmology Retina Division
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
PROGRAM OVERVIEW
This podcast series aims to increase the target clinicians’ awareness of factors that contribute to health disparities in patients with ocular disorders and potential barriers to care. Learn about leadership style and why increasing diversity within the eye care workforce is essential to patient care along with strategies for increasing representation. Enhance appreciation of the need for diverse representation in research in clinical trials, as this can lead to better access, and acquire tactics to increase underrepresented minority enrollment in clinical trials.
TARGET AUDIENCE
This activity is designed to meet the educational needs of clinicians in ophthalmology, retina specialties and optometry.
LEARNING OBJECTIVES
- Define factors that contribute to health disparities in patients with ocular diseases
- Formulate strategies to increase the participation of underrepresented groups in the eye care workforce
- Devise tactics to encourage increased diverse representation in research and clinical trials
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Judy E. Kim, MD has received consulting fees from Alimera Sciences, Allergan, Apellis, Astellas, Bausch + Lomb, Clearside Biomedical, DORC, Genentech, Notal Vision, Novartis, Outlook Therapeutics and Regeneron.
Adrienne W. Scott, MD has received consulting fees from Regeneron, Genentech/Roche, Iveric Bio, Apellis, EyePoint, Allergan/Abbvie and Alimera Sciences. Dr. Scott has received research fees for Non-CME/CE Services directly from a commercial interest or its agent from Genetech/Roche, and honoraria from Allergan/Abbvie and DORC.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with ineligible companies related to the content of this CME activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chimene Richa, MD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this online activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to Med Learning Group.
You will receive your certificate upon completion as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: April 21, 2023
EXPIRATION DATE: April 21, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Basil K. Williams, Jr., MD
Volunteer Associate Professor
Mary Knight Asbury Chair of Ophthalmic Pathology & Ocular Oncology
Department of Ophthalmology
University of Cincinnati College of Medicine
Cincinnati, OH
PROGRAM OVERVIEW
This podcast series aims to increase the target clinicians’ awareness of factors that contribute to health disparities in patients with ocular disorders and potential barriers to care. Learn about leadership style and why increasing diversity within the eye care workforce is essential to patient care along with strategies for increasing representation. Enhance appreciation of the need for diverse representation in research in clinical trials, as this can lead to better access, and acquire tactics to increase underrepresented minority enrollment in clinical trials.
TARGET AUDIENCE
This activity is designed to meet the educational needs of clinicians in ophthalmology, retina specialties and optometry.
LEARNING OBJECTIVES
- Define factors that contribute to health disparities in patients with ocular diseases
- Formulate strategies to increase the participation of underrepresented groups in the eye care workforce
- Devise tactics to encourage increased diverse representation in research and clinical trials
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Judy E. Kim, MD has participated on the advisory boards for Allergan, Astellas, Clearside Biomedical, DORC, Genentech, Notal Vision, Novartis, Outlook Therapeutics and Regeneron. Dr. Kim has conducted research for Optos.
Basil K. Williams, Jr., MD has received consulting fees from Allergan/AbbVie, Castle Biosciences, EyePoint Pharmaceuticals, Genentech and Regeneron.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chimene Richa, MD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this activity. To receive CME/CNE credit participants must:
- Read the CME information and faculty disclosures.
- Complete the pre-test before listening.
- Participate in the activity by listening to the podcast.
- Complete online post-test and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: April 21, 2023
EXPIRATION DATE: April 21, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Geeta Lalwani, MD
Vitreoretinal Diseases & Surgery
Rocky Mountain Retina Associates
Denver, CO
PROGRAM OVERVIEW
This podcast series aims to increase the target clinicians’ awareness of factors that contribute to health disparities in patients with ocular disorders and potential barriers to care. Learn about leadership style and why increasing diversity within the eye care workforce is essential to patient care along with strategies for increasing representation. Enhance appreciation of the need for diverse representation in research in clinical trials, as this can lead to better access, and acquire tactics to increase underrepresented minority enrollment in clinical trials.
TARGET AUDIENCE
This activity is designed to meet the educational needs of clinicians in ophthalmology, retina specialties and optometry.
LEARNING OBJECTIVES
- Define factors that contribute to health disparities in patients with ocular diseases
- Formulate strategies to increase the participation of underrepresented groups in the eye care workforce
- Devise tactics to encourage increased diverse representation in research and clinical trials
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Judy E. Kim, MD has participated on the advisory boards for Allergan, Astellas, Clearside Biomedical, DORC, Genentech, Notal Vision, Novartis, Outlook Therapeutics and Regeneron. Dr. Kim has conducted research for Optos.
Geeta Lalwani, MD has received consulting fees from Apellis and Iveric Bio. Dr. Lalwani has participated on the speaker’s bureau for Genentech, Regeneron, Apellis and Iveric Bio.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chimene Richa, MD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this activity. To receive CME/CNE credit participants must:
- Read the CME information and faculty disclosures.
- Complete the pre-test before listening.
- Participate in the activity by listening to the podcast.
- Complete online post-test and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: April 21, 2023
EXPIRATION DATE: April 21, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Sunir J. Garg, MD, FACS
Professor of Ophthalmology
Co-Director Retina Research Unit
The Retina Service of Wills Eye Hospital
Thomas Jefferson University
Philadelphia, PA
PROGRAM OVERVIEW
This podcast series aims to increase the target clinicians’ awareness of factors that contribute to health disparities in patients with ocular disorders and potential barriers to care. Learn about leadership style and why increasing diversity within the eye care workforce is essential to patient care along with strategies for increasing representation. Enhance appreciation of the need for diverse representation in research in clinical trials, as this can lead to better access, and acquire tactics to increase underrepresented minority enrollment in clinical trials.
TARGET AUDIENCE
This activity is designed to meet the educational needs of clinicians in ophthalmology, retina specialties and optometry.
LEARNING OBJECTIVES
- Define factors that contribute to health disparities in patients with ocular diseases
- Formulate strategies to increase the participation of underrepresented groups in the eye care workforce
- Devise tactics to encourage increased diverse representation in research and clinical trials
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Judy E. Kim, MD has participated on the advisory boards for Allergan, Astellas, Clearside Biomedical, DORC, Genentech, Notal Vision, Novartis, Outlook Therapeutics and Regeneron. Dr. Kim has conducted research for Optos.
Sunir J. Garg, MD, FACS has received consulting fees from Allergan, Apellis, Bausch + Lomb, Boehringer Ingelheim, Coherus, Johnson & Johnson, Kanaph and Merck Manuals. Dr. Garg has conducted contracted research for the American Academy of Ophthalmology, Apellis, Boehringer Ingelheim, Genentech, NGM Bio and Regeneron.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chimene Richa, MD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this activity. To receive CME/CNE credit participants must:
- Read the CME information and faculty disclosures.
- Complete the pre-test before listening.
- Participate in the activity by listening to the podcast.
- Complete online post-test and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: April 21, 2023
EXPIRATION DATE: April 21, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.